These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 33958857)
1. OSU-03012 Disrupts Akt Signaling and Prevents Endometrial Carcinoma Progression in vitro and in vivo. Ding L; Ren C; Yang L; Wu Z; Li F; Jiang D; Zhu Y; Lu J Drug Des Devel Ther; 2021; 15():1797-1810. PubMed ID: 33958857 [TBL] [Abstract][Full Text] [Related]
2. Ginkgolic acid induces apoptosis and autophagy of endometrial carcinoma cells via inhibiting PI3K/Akt/mTOR pathway in vivo and in vitro. Zhou L; Li S; Sun J Hum Exp Toxicol; 2021 Dec; 40(12):2156-2164. PubMed ID: 34132136 [TBL] [Abstract][Full Text] [Related]
3. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells. Lee TX; Packer MD; Huang J; Akhmametyeva EM; Kulp SK; Chen CS; Giovannini M; Jacob A; Welling DB; Chang LS Eur J Cancer; 2009 Jun; 45(9):1709-20. PubMed ID: 19359162 [TBL] [Abstract][Full Text] [Related]
4. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo. Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925 [TBL] [Abstract][Full Text] [Related]
5. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway. Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303 [TBL] [Abstract][Full Text] [Related]
6. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo. Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959 [TBL] [Abstract][Full Text] [Related]
7. 2,5-Dimethyl Celecoxib Inhibits Proliferation and Cell Cycle and Induces Apoptosis in Glioblastoma by Suppressing CIP2A/PP2A/Akt Signaling Axis. Gao D; Nyalali AMK; Hou Y; Xu Y; Zhou J; Zhao W; Huang B; Li F J Mol Neurosci; 2021 Aug; 71(8):1703-1713. PubMed ID: 33400072 [TBL] [Abstract][Full Text] [Related]
8. 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase. Porchia LM; Guerra M; Wang YC; Zhang Y; Espinosa AV; Shinohara M; Kulp SK; Kirschner LS; Saji M; Chen CS; Ringel MD Mol Pharmacol; 2007 Nov; 72(5):1124-31. PubMed ID: 17673571 [TBL] [Abstract][Full Text] [Related]
9. Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. Weng SC; Kashida Y; Kulp SK; Wang D; Brueggemeier RW; Shapiro CL; Chen CS Mol Cancer Ther; 2008 Apr; 7(4):800-8. PubMed ID: 18413793 [TBL] [Abstract][Full Text] [Related]
10. OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms. Zhang S; Suvannasankha A; Crean CD; White VL; Johnson A; Chen CS; Farag SS Clin Cancer Res; 2007 Aug; 13(16):4750-8. PubMed ID: 17699852 [TBL] [Abstract][Full Text] [Related]
11. OSU-03012, a non-Cox inhibiting celecoxib derivative, induces apoptosis of human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway. Liu J; Qin CK; Lv W; Zhao Q; Qin CY Anticancer Drugs; 2013 Aug; 24(7):690-8. PubMed ID: 23652278 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma. Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438 [TBL] [Abstract][Full Text] [Related]
13. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice]. Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587 [TBL] [Abstract][Full Text] [Related]
14. OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma. Gao M; Yeh PY; Lu YS; Hsu CH; Chen KF; Lee WC; Feng WC; Chen CS; Kuo ML; Cheng AL Cancer Res; 2008 Nov; 68(22):9348-57. PubMed ID: 19010909 [TBL] [Abstract][Full Text] [Related]
15. Targeting endoplasmic reticulum stress and Akt with OSU-03012 and gefitinib or erlotinib to overcome resistance to epidermal growth factor receptor inhibitors. Wang YC; Kulp SK; Wang D; Yang CC; Sargeant AM; Hung JH; Kashida Y; Yamaguchi M; Chang GD; Chen CS Cancer Res; 2008 Apr; 68(8):2820-30. PubMed ID: 18413750 [TBL] [Abstract][Full Text] [Related]
16. PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway. Zhang X; Zhong S Anticancer Agents Med Chem; 2020; 20(7):828-833. PubMed ID: 32188393 [TBL] [Abstract][Full Text] [Related]
17. A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer. Wang J; Wang HY; Shen Y; Liang D; Wang HY; Zhang SQ; Cao YX; Cao L Anticancer Drugs; 2019 Oct; 30(9):900-908. PubMed ID: 30913062 [TBL] [Abstract][Full Text] [Related]
18. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro. Yan W; Ma X; Zhao X; Zhang S Drug Des Devel Ther; 2018; 12():3961-3972. PubMed ID: 30510404 [TBL] [Abstract][Full Text] [Related]
19. Asparanin A from Zhang F; Zhang YY; Sun YS; Ma RH; Thakur K; Zhang JG; Wei ZJ J Agric Food Chem; 2020 Jan; 68(1):213-224. PubMed ID: 31861958 [TBL] [Abstract][Full Text] [Related]
20. miRNA omics reveal neferine induces apoptosis through Ca Ma FF; Ma RH; Thakur K; Zhang JG; Cao H; Wei ZJ; Simal-Gandara J Phytomedicine; 2024 Nov; 134():155988. PubMed ID: 39226708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]